discussion

Discussion.docx



RE: Where in the World Is Evidence-Based Practice?

Sackett (Sackett et al., 2000) defined Evidence-Based Practice (EBP) as the

conscientious use of current best evidence in making decisions about patient care.

However, the scope definition of EBP is much broader. EBP is a lifelong problem-

solving approach to clinical practice that integrates: A systematic search for and critical

appraisal of the most relevant and best research (i.e., external evidence) to answer a

burning clinical question, One's clinical expertise, including the use of internal evidence

generated from outcomes management or evidence-based quality improvement

projects, a thorough patient assessment, and evaluation and use of available resources

necessary to achieve desired patient outcomes, and patient/family preferences and

values (Melnyk, B. M., & Fineout-Overholt, E. (2018)). The goal of EBP is to utilize

current knowledge and connect it with patient preferences and clinical expertise to

standardize and improve the care process and, ultimately, patient outcomes. While

research is creating new knowledge, evidence-based practice is finding a way to

address a clinical problem. There are commonalities, but evidence-based practice looks

at outcomes directly related to that clinical question one is grappling with in practice

(2018).

The professional healthcare organization that I choose for review is Food and

Drug Administration (FDA). The United States Food and Drug Administration (FDA or

USFDA) is a federal organization of the Department of Health and Human Services.

The FDA is responsible for protecting and promoting public health through the control

and supervision of food safety, tobacco products, dietary supplements, prescription and

over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals,

etc., and veterinary products. The Food and Drug Administration's regulatory

approaches to marketing approval of the products it regulates are as varied as the

products themselves. At the heart of all FDA's medical product evaluation decisions is a

judgment about whether a new product's benefits to users will outweigh its risks. No

regulated product is risk-free, so these judgments are essential. In addition, the FDA

reviews the laboratory, animal, and human clinical testing companies to determine if the